Cite the Following Article
Advantages of PROTACs in achieving selective degradation of homologous protein families
Luxi Yang, Xinfei Mao, Jingyi Zhang, Jing Shu, Wenhai Huang, Xiaowu Dong, Yinqiao Chen and Mingfei Wu
Beilstein J. Org. Chem. 2026, 22, 628–661.
https://doi.org/10.3762/bjoc.22.49
How to Cite
Yang, L.; Mao, X.; Zhang, J.; Shu, J.; Huang, W.; Dong, X.; Chen, Y.; Wu, M. Beilstein J. Org. Chem. 2026, 22, 628–661. doi:10.3762/bjoc.22.49
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
| Picture with graphical abstract, title and authors for social media postings and presentations. | ||
| Format: PNG | Size: 11.4 MB | Download |
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Bisi, N.; Hamze, A. Dual PROTACs Versus Dual Inhibitors in Oncology: A Medicinal Chemistry and Linker Design Perspective. Pharmaceuticals 2026, 19, 1146. doi:10.3390/ph19081146
